• 1
    Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359384.
  • 2
    Tan DX, Manchester LC, Reiter RJ et al. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 2000; 9: 137159.
  • 3
    Reiter RJ, Tan DX. What constitutes a physiological concentration of melatonin? J Pineal Res 2003; 34: 7980.
  • 4
    Skinner DC, Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999; 140: 43994405.
  • 5
    Tan D, Manchester LC, Reiter RJ et al. High physiological levels of melatonin in the bile of mammals. Life Sci 1999;65: 25232529.
  • 6
    Pappolla MA, Sos M, Omar RA et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 1997; 17: 16831690.
  • 7
    Pappolla MA, Chyan Y-J, Poeggeler B et al. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm 2000; 107: 203231.
  • 8
    Acuna-Castroviejo D, Coto-Montes A, Gaia MM et al. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 1997; 60: L23L29.
  • 9
    Iacovitti L, Stull ND, Johnston K. Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res 1997; 768: 317326.
  • 10
    Mayo JC, Sainz RM, Uria H et al. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J Pineal Res 1998; 24: 179192.
  • 11
    Melchiorri D, Reiter RJ, Sewerynek E et al. Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions. FASEB J 1995; 9: 12051210.
  • 12
    Giusti P, Lipartiti M, Gusella M et al. In vitro and in vivo protective effects of melatonin against glutamate oxidative stress and neurotoxicity. Ann N Y Acad Sci 1997; 825: 7984.
  • 13
    Carneiro RC, Reiter RJ. Melatonin protects against lipid peroxidation induced by delta-aminolevulinic acid in rat cerebellum, cortex and hippocampus. Neuroscience 1998; 82: 293299.
  • 14
    Princ FG, Maxit AG, Cardalda C et al. In vivo protection by melatonin against delta-aminolevulinic acid-induced oxidative damage and its antioxidant effect on the activity of haem enzymes. J Pineal Res 1998; 24: 18.
  • 15
    Shaikh AY, Xu J, Wu Y et al. Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death. Neurosci Lett 1997; 229: 193197.
  • 16
    Gitto E, Karbownik M, Reiter RJ et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50: 756760.
  • 17
    Fulia F, Gitto E, Cuzzocrea S et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001; 31: 343349.
  • 18
    Hirata F, Hayaishi O. Studies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate. J Biol Chem 1975; 250: 59605966.
  • 19
    Hardeland R, Balzer I, Poeggeler B et al. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J Pineal Res 1995; 18: 104111.
  • 20
    Tan DX, Manchester LC, Reiter RJ et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 2000; 29: 11771185.
  • 21
    Carampin P, Rosan S, Dalzoppo D et al. Some biochemical properties of melatonin and the characterization of a relevant metabolite arising from its interaction with H2O2. J Pineal Res 2003; 34: 134142.
  • 22
    Hirata F, Hayaishi O, Tokuyama T et al. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 1974; 249: 13111313.
  • 23
    de Oliveira SS, Ximenes VF, Catalani LH et al. Myeloperoxidase-catalyzed oxidation of melatonin by activated neutrophils. Biochem Biophys Res Commun 2000; 279: 657662.
  • 24
    Grace MS, Cahill GM, Besharse JC. Melatonin deacetylation: retinal vertebrate class distribution and Xenopus laevis tissue distribution. Brain Res 1991; 559: 5663.
  • 25
    Pellegrino LG, Pellegrino AS, Cushman AJ. A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York, 1979; pp. 1122.
  • 26
    Pang SF, Yu HS, Suen HC et al. Melatonin in the retina of rats: a diurnal rhythm. J Endocrinol 1980; 87: 8993.
  • 27
    Pozdeyev NV, Lavrikova EV. Diurnal changes of tyrosine, dopamine, and dopamine metabolites content in the retina of rats maintained at different lighting conditions. J Mol Neurosci 2000; 15: 19.
  • 28
    Tosini G, Menaker M. The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration. Brain Res 1998; 789: 221228.
  • 29
    Hamm HE, Takahashi JS, Menaker M. Light-induced decrease of serotonin N-acetyltransferase activity and melatonin in the chicken pineal gland and retina. Brain Res 1983; 266: 287293.
  • 30
    Zawilska JB, Jarmak A, Woldan-Tambor A et al. Light-induced suppression of nocturnal serotonin N-acetyltransferase activity in chick pineal gland and retina: a wavelength comparison. J Pineal Res 1995; 19: 8792.
  • 31
    Pozdeyev NV, Iuvone PM. Novel mechanism of light-induced degradation of melatonin in the retina. J Neurochem 2001; 78 (Suppl. 1):156.
  • 32
    Hardeland R, Reiter RJ, Poeggeler B et al. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993; 17: 347357.
  • 33
    Mahal HS, Sharma HS, Mukherjee T. Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 1999; 26: 557565.
  • 34
    Scaiano JC. Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry. J Pineal Res 1995; 19: 189195.
  • 35
    Stasica P, Ulanski P, Rosiak JM. Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998; 25: 6566.
  • 36
    Andrisano V, Bertucci C, Battaglia A et al. Photostability of drugs: photodegradation of melatonin and its determination in commercial formulations. J Pharm Biomed Anal 2000; 23: 1523.
  • 37
    Fowler G, Daroszewska M, Ingold KU. Melatonin does not ‘‘directly scavenge hydrogen peroxide“: demise of another myth. Free Radic Biol Med 2003; 34: 7783.
  • 38
    Menendez-Pelaez A, Poeggeler B, Reiter RJ et al. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53: 373382.
  • 39
    Ferreira SA, Rollag MD, Glass JD. Pharmacokinetics of extracellular melatonin in Siberian hamster forebrain. Brain Res 1996; 733: 318320.
  • 40
    Yeleswaram K, McLaughlin LG, Knipe JO et al. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J Pineal Res 1997; 22: 4551.
  • 41
    Reiter RJ, Tan DX, Manchester LC et al. Antioxidative capacity of melatonin. In: Handbook of Antioxidants, 2nd edn. CadenasE, PackerL eds, Marcell Dekker, New York, 2002; pp. 565613.
  • 42
    Cheung RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34: 153160.
  • 43
    Pablos MI, Guerrero JM, Ortiz GG. Both melatonin and a putative nuclear melatonin receptor agonist CGP 52608 stimulate glutathione peroxidase and glutathione reductase activities in mouse brain in vivo. Neuroendocrinology Lett 1997; 18: 4958.
  • 44
    Burkhardt S, Reiter RJ, Tan DX et al. DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol 2001; 33: 775783.
  • 45
    Tan DX, Manchester LC, Burkhardt S et al. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 22942296.
  • 46
    Lopez-Burillo S, Tan DX, Rodriguez-Gallego V et al. Melatonin and its derivatives cyclic 3-hydroxymelatonin, N1-acetyl-N2-formyl-5-methoxykynuramine and 6-methoxymelatonin reduce oxidative DNA damage induced by Fenton reagents. J Pineal Res 2003; 34: 178184.